Browse articles from EyeWorld.org related to ASCRS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA accepts IND for presbyopia-correcting eye drop
➤ Pivotal study of new tech against gold standard patching treatment of amblyopia
➤ Topline results from trial to reverse pharmacologically induced mydriasis
➤ Pivotal study of fixed-combination tropicamide/phenylephrine product for mydriasis
➤ ASCRS introduces new Richard L. Lindstrom Lecture
➤ FDA accepts NDA for fixed-combination mydriatic agent
➤ NDA accepted by FDA for dry eye nasal spray
➤ NDA submitted for drop to treat presbyopia
➤ Study to assess outcomes of ab interno canaloplasty
➤ Largest study of glaucoma genetics published
➤ Iridex and Topcon enter into strategic agreement
➤ COVID-19 vaccine update
➤ ASCRS Journal Club on March 11
The ASCRS Master Class in Refractive Surgery, 20/Happy in 2020, will be available for purchase as a nine-module digital set eligible for 18 hours of AMA PRA Category 1 Credits. Recordings will also remain available through the year for attendees who registered for the live program.
ASCRS announced that the 2021 Annual Meeting will be held July 23–27 in Las Vegas, Nevada, moving from the previous location of San Francisco, California. The move to Las Vegas allows ASCRS to have its first meeting in 800+ days in as safe a meeting venue as can be reasonably organized.
ASCRS relies partially on unrestricted educational grant support to bring both live and online CME programs to its membership. Here we explain the grant writing process and how important the ASCRS and industry relationship is to continuing education.
ASCRS began its Grand Rounds in October 2020 as a monthly CME opportunity for members. The Grand Rounds are hosted in partnership with major academic institutions and feature two challenging cases with panel discussions. Watch the full programs online to hear the panel’s thoughts and how the cases were ultimately handled.
Recaps of a few recent papers from the Journal of Cataract & Refractive Surgery
➤ PMA submitted to FDA for small-aperture IOL
➤ Preclinical results for new class of non-prostaglandin analogs for IOP lowering
➤ A Phase 2 clinical trial begins enrollment for topical presbyopia-correcting drop
➤ Home OCT technology used in clinical trial to reduce participant visits to offices
➤ ASCRS Journal Club on March 11
➤ 2021 ASCRS Annual Meeting update
➤ FDA approves new monofocal IOL
➤ First patient dosed in Phase 2 trial for investigational DED therapy
➤ Phase 2a trial initiated for add-on wet AMD therapy
➤ Topline results from Phase 3 studies for nAMD treatment
➤ Phase 2 trial of betamethasone treatment for cataract surgery pain and inflammation
➤ Fast Track designation given to therapy seeking to treat achromatopsia
➤ Topline data from Phase 1 trial of travoprost intracameral implant
➤ ASCRS Journal Club